These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2060591)

  • 21. Quantitative studies of the antagonism by naloxone and N-cyclopropylmethyl-norazido-dihydroisomorphine (CAM) of different opiates.
    Fürst S; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):115-25. PubMed ID: 6897745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population differences in benzodiazepine sensitive male scent-induced analgesia in the deer mouse, Peromyscus maniculatus.
    Kavaliers M; Innes DG
    Pharmacol Biochem Behav; 1989 Mar; 32(3):613-9. PubMed ID: 2544899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors.
    Raghavendra V; Kulkarni SK
    Brain Res; 1999 Jul; 834(1-2):178-81. PubMed ID: 10407111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems.
    Guo JY; Wang JY; Luo F
    J Psychopharmacol; 2010 Oct; 24(10):1561-7. PubMed ID: 19395430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid.
    Shavali S; Ho B; Govitrapong P; Sawlom S; Ajjimaporn A; Klongpanichapak S; Ebadi M
    Brain Res Bull; 2005 Jan; 64(6):471-9. PubMed ID: 15639542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesic effects of the putative FSH-suppressing gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one: possible modes of action.
    Wiebe JP; Kavaliers M
    Brain Res; 1988 Sep; 461(1):150-7. PubMed ID: 3147122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A benzodiazepine antagonist, Ro 15-1788, can block the phase-shifting effects of triazolam on the mammalian circadian clock.
    Van Reeth O; Vanderhaeghen JJ; Turek FW
    Brain Res; 1988 Mar; 444(2):333-9. PubMed ID: 3129143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxone blocks the beneficial effects of aqueous extract of Murraya koenigii (L.) Spreng leaves in models of pain.
    Gupta R; Gupta LK; Bhattacharya SK
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1748-51. PubMed ID: 23852898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia.
    Mogil JS; Belknap JK
    Pharmacol Biochem Behav; 1997 Jan; 56(1):61-6. PubMed ID: 8981610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective stimulation of daily LH secretion by the combined treatment with melatonin and naloxone in luteal-phase ewes.
    Misztal T; Romanowicz K
    Acta Neurobiol Exp (Wars); 2005; 65(1):1-9. PubMed ID: 15794026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analgesic effects of peripheral and central administration of melatonin in rats.
    Yu CX; Zhu B; Xu SF; Cao XD; Wu GC
    Eur J Pharmacol; 2000 Sep; 403(1-2):49-53. PubMed ID: 10969143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antinociceptive effects and pharmacological properties of JM-1232(-): a novel isoindoline derivative.
    Chiba S; Nishiyama T; Yamada Y
    Anesth Analg; 2009 Mar; 108(3):1008-14. PubMed ID: 19224817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
    Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Male scent-induced analgesia in the deer mouse, Peromyscus maniculatus: involvement of benzodiazepine systems.
    Kavaliers M; Innes DG
    Physiol Behav; 1988; 42(2):131-5. PubMed ID: 2835786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
    Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
    Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of a nociceptive reaction by opioid antagonists in mice.
    Jacob JJ; Ramabadran K
    Br J Pharmacol; 1978 Sep; 64(1):91-8. PubMed ID: 698486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors.
    Pierrefiche G; Zerbib R; Laborit H
    Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):131-42. PubMed ID: 7905658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.